Senior officials in the Trump administration are encouraging vaccine skepticism − and it's jeopardizing the health of our rapidly aging population.

Biotechnology company Moderna (NASDAQ:MRNA) announced better-than-expected revenue in Q2 CY2025, but sales fell by 41.1% year ...